Brian K. Halak, 10% Owner at Dicerna Pharmaceuticals Inc (DRNA), sold 997,149 shares at $13.60 ($13.6M) on 2018-10-31, disclosed to the SEC on 2018-11-05.
Open-market sale of $13.6M DRNA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.68 | 1,136 | $16K | 0.1% |
| 2 | $13.68 | 152,364 | $2.1M | 15.3% |
| 3 | $13.68 | 152,364 | $2.1M | 15.3% |
| 4 | $14.31 | 678 | $10K | 0.1% |
| 5 | $14.31 | 90,918 | $1.3M | 9.5% |
| 6 | $14.31 | 90,918 |
| $1.3M |
| 9.5% |
| 7 | $13.60 | 959 | $13K | 0.1% |
| 8 | $13.60 | 128,670 | $1.7M | 12.8% |
| 9 | $13.37 | 1,408 | $19K | 0.1% |
| 10 | $13.37 | 188,867 | $2.5M | 18.5% |
| 11 | $13.37 | 188,867 | $2.5M | 18.5% |
| Total | $13.67 avg | 997,149 | $13.6M | 100% |
| Filing → |
| EVOK | SELL | 2015-08-20 | $1K | — | Filing → |
| ESPR | BUY | 2014-10-21 | $10.0M | — | Filing → |
| ATRA | BUY | 2014-10-21 | $20K | — | Filing → |